AngioDynamics (Nasdaq:ANGO) shares are up today on second-quarter results that topped the consensus forecast. Shares of ANGO were up more than 11% at $15.24 apiece by the late morning. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up more than 7%. The Latham, New York–based peripheral […]
MiMedx appoints chief operating officer
MiMedx (Nasdaq:MDXG) announced that it appointed Ricci S. Whitlow as its chief operating officer (COO). Whitlow’s responsibilities include leading manufacturing, supply chain, procurement, quality and regulatory efforts. She joins from Catalent, where she most recently served as president of clinical supply services. “We are happy to begin 2023 with the addition of Ricci Whitlow to […]
Know Labs wins new glucose monitoring patent
Know Labs (NYSE:KNW) announced today that it received a new patent equating its diagnostic technology to the current glucose monitoring standard. Seattle-based Know Labs develops the Bio-RFID technology. It uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. It integrate into wearable, mobile or bench-top form factors. […]
EndoStim prepares FDA PMA submission for neurostim implant that treats GERD
EndoStim announced today that it held a pre-submission meeting with the FDA regarding its implantable neurostimulation treatment for GERD. The pre-submission meeting comes in advance of a premarket approval (PMA) submission for the system. Santa Ana, California-based EndoStim designed it to treat drug-refractory gastroesophageal reflux disease (GERD). EndoStim received FDA breakthrough device designation for the […]
Asensus Surgical announces another surgical robot placement in Japan
Asensus Surgical (NYSE:ASXC) announced today that it entered into a lease agreement with a Japanese hospital for its Senhance surgical robot. Research Triangle Park, North Carolina-based Asensus entered the agreement with Kitakyushu General Hospital. It marks the second Senhance system leased at the hospital in the Kyushu area of Japan. Asensus placed the first one […]
Opteev to unveil breath analyzer that detects COVID-19, flu, RSV
Opteev Technologies announced today that it intends to debut its ViraWarn breath analyzer that detects respiratory viruses at CES 2023. Baltimore-based Opteev designed its analyzer to detect COVID-19, influenza and RSV with results in less than 60 seconds. It aims for the multiple-use, rechargeable analyzer to become an affordable diagnostic option. The company plans to […]
Burning Rock wins FDA breakthrough nod for multi-cancer blood test
Burning Rock (Nasdaq:BNR) announced today that the FDA granted breakthrough device designation to its OverC blood test. Irvine, California-based Burning Rock developed OverC as a multi-cancer detection blood test (MCDBT). It designed the test to detect cancer types including esophageal, liver, lung, ovarian and pancreatic cancers. Adults of either sex, aged 50-75 years old, at […]
Study backs use of Masimo hemoglobin monitoring during cesarean delivery
Masimo (Nasdaq:MASI) today announced positive data from a study of its hemoglobin monitoring for patients undergoing cesarean section. The study observed patients undergoing elective cesarean section (CS) with antepartum hemorrhage. Researchers used noninvasive, continuous hemoglobin monitoring with Masimo SpHb. The study demonstrated significant positive correlations between SpHb and invasive hemoglobin (Hb) values. “In patients undergoing […]
Ypsomed, Mediq complete sale of DiaExpert
Ypsomed and Mediq announced today that they completed the sale of mail-order retailer for diabetes care DiaExpert. Germany-based DiaExpert specializes in insulin pump therapy. The companies previously announced the sale of DiaExpert in October. This sale allows Ypsomed to focus on the manufacture and sale of its own medical technologies. That focus continues to narrow […]
Datar wins FDA breakthrough nod for brain tumor-detecting blood test
Datar Cancer Genetics announced that it received FDA breakthrough device designation for its TriNetra-Glio blood test. TriNetra-Glio aids in the diagnosis of brain tumors. It represents the third test from Datar to receive the FDA’s breakthrough device designation. The test joins Datar’s early-stage breast and prostate cancer detection tests. According to a news release, the […]
Visby Medical wins FDA EUA for respiratory health test
Visby Medical announced today that it received FDA emergency use authorization (EUA) for its Respiratory Health point-of-care test. San Jose, California–based Visby designed its polymerase chain reaction (PCR) test for the fast detection of respiratory infections. Influenza (flu) A and B, as well as SARS-CoV-2 (COVID-19) can cause these upper respiratory infections. The PCR test […]